Patent ID: 9050353
Filing Date: 2015-06-09
Classification: A61K,A61P

Abstract:
1. A method for alleviating or repairing a disease and/or disorder associated with a nervous system myelin sheath lesion, comprising administering icariin to a patient in need thereof: further comprising any one of the following items a) to b): a) the disease and/or disorder associated with nervous system myelin sheath lesion is selected from: optical neuromyelitis, acute disseminated encephalomyelitis, diffuse sclerosis, concentric circle sclerosis, central pontine myelinolysis, acute inflammatory demyelinating polyneuropathy, and chronic inflammatory demyelinating polyneuropathy; or b) the disease and/or disorder associated with nervous system myelin sheath lesion is selected from: subacute combined degeneration caused by nutrition deficiency diseases, subacute sclerosing panencephalitis caused by viral infection or progressive multifocal leukoencephalopathy, and diabetic neuropathy; wherein icariin is administered in amounts from 0.1 μg to 250 mg per kilogram bodyweight per day.